INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 108 filers reported holding INTERSECT ENT INC in Q2 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,000 | 0.0% | 40 | +5.3% | 0.00% | – |
Q3 2021 | $1,000 | -94.1% | 38 | -96.2% | 0.00% | -100.0% |
Q2 2021 | $17,000 | -19.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $21,000 | -8.7% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $23,000 | +43.8% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $16,000 | +14.3% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $14,000 | +16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $12,000 | -52.0% | 1,000 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $25,000 | +47.1% | 1,000 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $17,000 | -26.1% | 1,000 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $23,000 | -28.1% | 1,000 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $32,000 | +14.3% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $28,000 | -3.4% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $29,000 | -21.6% | 1,000 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $37,000 | +825.0% | 1,000 | +323.7% | 0.00% | +300.0% |
Q3 2016 | $4,000 | – | 236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |